These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2686813)

  • 1. Myasthenia gravis and lymphoblastic lymphoma antiacetylcholine receptor antibody as a tumor marker--a case report.
    Mortimer JE; Kidd P
    Cancer Invest; 1989; 7(4):327-31. PubMed ID: 2686813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA antigens and acetylcholine receptor antibodies in penicillamine induced myasthenia gravis.
    Garlepp MJ; Dawkins RL; Christiansen FT
    Br Med J (Clin Res Ed); 1983 Jan; 286(6362):338-40. PubMed ID: 6402089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of acetylcholine receptor antibody in relatives of myasthenic patients.
    Walker GL; Nicholson LV; Mastaglia FL
    Lancet; 1980 Apr; 1(8171):778-9. PubMed ID: 6103204
    [No Abstract]   [Full Text] [Related]  

  • 4. Postthymectomy myasthenia gravis: relationship with thymoma and antiacetylcholine receptor antibody.
    Nakajima J; Murakawa T; Fukami T; Sano A; Takamoto S; Ohtsu H
    Ann Thorac Surg; 2008 Sep; 86(3):941-5. PubMed ID: 18721587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of myasthenia gravis following sarcoidosis and Hashimoto's thyroiditis].
    Nishida H; Tanaka Y; Nakao N; Ibi T; Sahashi K
    Rinsho Shinkeigaku; 2000 Aug; 40(8):797-800. PubMed ID: 11218699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral immunity before and after thymectomy in myasthenia gravis.
    Scadding GK; Webster AD; Ross M; Thomas HC; Havard CW
    Neurology; 1979 Apr; 29(4):502-6. PubMed ID: 312471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human muscle acetylcholine receptor reactive T and B lymphocytes in myasthenia gravis.
    Yi Q; Lefvert AK
    Ann N Y Acad Sci; 1993 Jun; 681():339-41. PubMed ID: 8357186
    [No Abstract]   [Full Text] [Related]  

  • 8. Mesangial proliferative glomerulonephritis with deposits of anti-nicotinic acetylcholine receptor antibody in a patient with myasthenia gravis.
    Mitsui T; Okada K; Kuhara T; Hashizume T; Okazaki S; Kawajiri M; Matsumoto T
    J Clin Neurosci; 2001 Sep; 8(5):454-6. PubMed ID: 11535018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiacetylcholine receptor antibody and its relationship to HLA type in asymptomatic siblings of a patient with myasthenia gravis.
    Seybold ME; Lindstrom JM
    Neurology; 1981 Jun; 31(6):778-80. PubMed ID: 7195498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity in myasthenia gravis: HLA phenotypes and autoantibody responses in ocular and generalized types.
    Kida K; Hayashi M; Yamada I; Matsuda H; Yoshinaga J; Takami S; Yashiki S; Sonoda S
    Ann Neurol; 1987 Mar; 21(3):274-8. PubMed ID: 3606034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA antigens and acetylcholine receptor antibody in the subclassification of myasthenia gravis in Hong Kong Chinese.
    Hawkins BR; Ip MS; Lam KS; Ma JT; Wy CL; Yeung RT; Dawkins RL
    J Neurol Neurosurg Psychiatry; 1986 Mar; 49(3):316-9. PubMed ID: 3958744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VH gene family utilization of antiacetylcholine receptor antibodies in experimental autoimmune myasthenia gravis.
    Graus Y; Verschuuren J; Bos N; van Breda Vriesman P; De Baets M
    Ann N Y Acad Sci; 1993 Jun; 681():285-7. PubMed ID: 8357170
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibodies to synthetic peptide (125-148) of the alpha-subunit of human nicotinic acetylcholine receptor in sera from patients with myasthenia gravis.
    Ohta M; Ohta K; Itoh N; Nishitani H; Hara H; Hayashi K
    Neurology; 1990 Nov; 40(11):1776-8. PubMed ID: 2234435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antibodies to acetylcholine receptor. Diagnosis and therapeutic interest in myasthenia gravis (author's transl)].
    de Crousaz G
    Ann Chir; 1980 Mar; 34(3):188-92. PubMed ID: 7369693
    [No Abstract]   [Full Text] [Related]  

  • 15. Myasthenia gravis: nicotinic acetylcholine receptors as targets for autoimmune attack.
    Newsom-Davis J; Harcourt G; Beeson D
    Biochem Soc Trans; 1989 Aug; 17(4):635-7. PubMed ID: 2670631
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value.
    Lindstrom JM; Seybold ME; Lennon VA; Whittingham S; Duane DD
    Neurology; 1976 Nov; 26(11):1054-9. PubMed ID: 988512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up study of relapse in symptoms and reelevation of acetylcholine receptor antibody titers in patients with myasthenia gravis.
    Komiya T; Sato T
    Ann N Y Acad Sci; 1988; 540():605-7. PubMed ID: 3207287
    [No Abstract]   [Full Text] [Related]  

  • 18. Correlation between acetylcholine receptor antibody titer and HLA-B8 and HLA-DRw3 antigens in myasthenia gravis.
    Keesey J; Naeim F; Lindstrom J; Zeller E; Herrmann C; Walford R
    Trans Am Neurol Assoc; 1978; 103():188-90. PubMed ID: 757055
    [No Abstract]   [Full Text] [Related]  

  • 19. Humoral immunity in myasthenia gravis: effect of steroids and thymectomy.
    Tindall RS
    Neurology; 1980 May; 30(5):554-7. PubMed ID: 7189263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ELISA for detection of IgG & IgM antibodies to human nicotinic acetylcholine receptor in myasthenia gravis.
    Jailkhani BL; Asthana D; Jaffery NF; Khajuria A; Subbalaxmi B; Ahuja GK
    Indian J Med Res; 1986 Feb; 83():187-95. PubMed ID: 3710546
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.